Sklamberg Quoted in The Pink Sheet on FDA Toolkit for Off-Site Compliance Inspections
August 26, 2020
Life Sciences & Healthcare Regulatory partner Howard Sklamberg was quoted in an article from The Pink Sheet, "What The FDA's Inspections Q&A Guidance Really Means: It's Time To Offer Virtual Inspections." The article examines industry feedback on recent FDA guidelines about evaluating manufacturing compliance without on-site inspections due to the COVID-19 pandemic.
» Read the full article (subscription required).
